AYTU BIOSCIENCE
Aytu BioScience is a specialty healthcare company concentrating on developing products for redox-modulated conditions with a focus on urological indications and related conditions. Aytu BioScience is initially concentrating on male sexual dysfunction and male infertility and will seek expansion opportunities in other urological indications.
AYTU BIOSCIENCE
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2002-01-01
Address:
Englewood, Colorado, United States
Country:
United States
Website Url:
http://www.aytubio.com
Total Employee:
101+
Status:
Active
Contact:
1(720) 437-6580
Email Addresses:
[email protected]
Total Funding:
52.48 M USD
Technology used in webpage:
Euro Amazon HSTS IPv6 Nginx Google Google Cloud Apple Mobile Web App Capable Common Name Invalid Amazon Virginia Region
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Assuré Medical
Assuré Medical is a urethral care company focused on developing non-antibiotic, patient-led solutions for chronic urethral conditions.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-12-10 | Neos Therapeutics | Neos Therapeutics acquired by Aytu BioScience | 44.9 M USD |
| 2019-09-12 | Innovus Pharmaceuticals | Innovus Pharmaceuticals acquired by Aytu BioScience | N/A |
| 2017-05-09 | Nuelle | Nuelle acquired by Aytu BioScience | N/A |
Investors List
Eclipse Business Capital
Eclipse Business Capital investment in Post-IPO Debt - Aytu BioScience
Stonepine Capital Management
Stonepine Capital Management investment in Post-IPO Equity - Aytu BioScience
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - Aytu BioScience
Avenue Capital Group
Avenue Capital Group investment in Post-IPO Debt - Aytu BioScience
Official Site Inspections
http://www.aytubio.com Semrush global rank: 3.59 M Semrush visits lastest month: 3.59 K
- Host name: 3.246.109.208.host.secureserver.net
- IP address: 208.109.246.3
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Aytu BioScience"
About - Aytu BioPharma
Josh led the commercial organization since the company’s inception and led the launch of the company’s first product, subsequently launching numerous products and scaling the …See details»
AYTU BioScience, Inc. NASDAQ: AYTU - Aytu BioPharma
Commercial organization to over 150 people across sales, marketing, payer markets, distribution, commercial operations, and national accounts. In less than four years, Arbor grew from a …See details»
Investor Relations - Aytu BioPharma
Nov 6, 2024 Aytu BioPharma, Inc. Denver Corporate Center III. 7900 E. Union Avenue. Suite 920 Denver, CO 80237 USA +1 (855) AYTU BIO (+1 855-298-8246)See details»
Corporate Governance - Aytu BioPharma
Our board of directors, senior executive officers, and senior financial executives adhere to a high standard of ethics and business practices at all times, and our management team sets a …See details»
Aytu BioPharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 1(720) 437-6580 Aytu BioScience is a specialty healthcare company concentrating on developing products for redox-modulated conditions …See details»
IR Contacts - Aytu BioPharma
For investor-specific information, please send an email to [email protected]. Home. Leadership. Products. Pipeline. Investors. Careers. Contact. News. Aytu BioPharma, Inc. …See details»
Aytu BioPharma - LinkedIn
Aytu BioPharma (NASDAQ: AYTU) is a dynamic specialty pharmaceutical company with a growing commercial portfolio of prescription medicines addressing complex conditions, with a …See details»
Aytu BioPharma, Inc. (AYTU) Company Profile & Facts - Yahoo …
See the company profile for Aytu BioPharma, Inc. (AYTU) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Josh Disbrow - Co-Founder & Chief Executive Officer - LinkedIn
Co-Founder & Chief Executive Officer of Aytu BioPharma, Inc. (Nasdaq: AYTU) · Leading Aytu BioPharma since our founding in 2015; Aytu BioPharma is a patient-centric, dynamic …See details»
Aytu BioPharma CEO and Key Executive Team | Craft.co
Aytu BioPharma's Chairman and Chief Executive Officer is Josh Disbrow. Other executives include Mark Oki, Chief Financial Officer; Jarrett Disbrow, Chief Business Officer and 11 …See details»
AYTU BioScience, Inc. OTCQX: AYTU - Aytu BioPharma
Www.aytubio.com Industry: Specialty Pharmaceuticals, Life Sciences Year End: June 30 SHARE DISTRIBUTION Outstanding: 4.0 million STOCK SUMMARY Symbol: OTCQX:AYTUD Price: …See details»
Nominating and Governance Committee Charter - Aytu BioPharma
Jul 26, 2016 Aytu BioPharma is a pharmaceutical company developing and commercializing novel therapeutics with a focus on pediatrics and pediatric-onset conditions.See details»
Aytu BioPharma Subleases a Portion of Its Manufacturing Facility
May 1, 2023 This sublease represents over 30% of the Company's FDA and DEA-approved pharmaceutical manufacturing facility. In addition, commencing as early as April 1, 2024, but …See details»
Aytu BioPharma Announces Sale of Consumer Health Business …
Aug 6, 2024 Aytu finalized the acquisition of Innovus Pharmaceuticals, Inc. in February 2020, and has been operating the Consumer Health business unit as its wholly-owned subsidiary …See details»
ESG Committee Charter - Aytu BioPharma
Organization The Environmental, Social and Governance Committee (the “ Committee ”) serving on behalf of the Board of Directors of Aytu BioPharma, Inc. (the “ Company ”) was established …See details»
Aytu BioPharma - Craft
Oct 11, 2024 Aytu BioPharma is a specialty pharmaceutical company focused on developing and commercializing novel products in the field of urology. Aytu is initially concentrating on …See details»
Investor FAQs - Aytu BioPharma - investors.aytubio.com
Who is Aytu BioPharma’s legal counsel? Dorsey & Whitney, LLP. 1400 Wewatta Street. Suite 400. Denver, CO 80202-5549. 303-629-3400.See details»
Aytu BioPharma Ranked Among Fastest-Growing Companies in …
Nov 8, 2023 Now in its 29th year, the Deloitte Technology Fast 500 recognizes the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech …See details»
Events and Presentations - Aytu BioPharma
Sep 26, 2024 Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024. Event Date: Wednesday, November 13, 2024, at 4:30 p.m. …See details»